TABLE 4

Reference Tissue Kinetic Data Using Time–Activity Curve Analysis (with Outliers)

Pharmacokinetic parameterHRRT reconstruction methodUnfixed interceptFixed intercept to origin
SlopeInterceptrSloper
RLogan DVR3D-FBP1.10 ± 0.510.02 ± 0.510.97 ± 0.011.10 ± 0.440.97 ± 0.01
3D-FBP G60.99 ± 0.430.06 ± 0.440.98 ± 0.001.00 ± 0.370.98 ± 0.01
3D-OSWLS0.98 ± 0.240.01 ± 0.270.98 ± 0.010.98 ± 0.220.98 ± 0.01
3D-OSWLS G60.85 ± 0.200.10 ± 0.210.98 ± 0.000.87 ± 0.180.98 ± 0.00
RPM BPND3D-FBP1.11 ± 0.560.11 ± 0.230.97 ± 0.011.14 ± 0.540.97 ± 0.01
3D-FBP G60.96 ± 0.450.16 ± 0.380.97 ± 0.021.00 ± 0.440.96 ± 0.05
3D-OSWLS1.00 ± 0.25−0.05 ± 0.460.98 ± 0.010.99 ± 0.250.97 ± 0.01
3D-OSWLS G60.86 ± 0.20−0.05 ± 0.290.98 ± 0.000.85 ± 0.200.98 ± 0.01
  • G6 = 6-mm FWHM gaussian kernel.

  • Slope, intercept, and r (all data are mean ± SD) of reference tissue (pons) kinetic data using HRRT- vs. HR+-reconstructed scans of 6 subjects, over various ROIs.